NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
-20.18%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.95B
AUM Growth
+$1.95B
(-44%)
Cap. Flow
-$601M
Cap. Flow
% of AUM
-30.89%
Top 10 Holdings %
Top 10 Hldgs %
66.18%
Holding
59
New
2
Increased
9
Reduced
4
Closed
2
Top Buys
| 1 |
Trevi Therapeutics
TRVI
|
$32M |
| 2 |
IVA
Inventiva
IVA
|
$24.2M |
| 3 |
Palo Alto Networks
PANW
|
$15.4M |
| 4 |
Nkarta
NKTX
|
$8.21M |
| 5 |
Senti Biosciences
SNTI
|
$7.46M |
Top Sells
| 1 |
Robinhood
HOOD
|
$644M |
| 2 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$13M |
| 3 |
IonQ
IONQ
|
$12.8M |
| 4 |
Enliven Therapeutics
ELVN
|
$2.81M |
| 5 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
$787K |
Sector Composition
| 1 | Healthcare | 69.32% |
| 2 | Technology | 12.48% |
| 3 | Consumer Staples | 11.56% |
| 4 | Industrials | 4.58% |
| 5 | Communication Services | 1.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
51
DELISTED
Regulus Therapeutics
RGLS
| $2.99M | 0.15% |
1,445,115
| – | – |
|
52
Wheels Up
UP
$1.63B
| $2.07M | 0.11% |
106,126
| – | – |
|
|
53
Enliven Therapeutics
ELVN
$1.24B
| $1.23M | 0.06% |
251,681
-575,342
| -70% | -$2.81M |
|
|
ADXN
54
Addex Therapeutics
ADXN
$8.65M
| $1.08M | 0.06% |
47,072
+38,072
| +423% | +$876K |
|
|
TCON
55
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $693K | 0.04% |
17,336
| – | – |
|
|
LUMO
56
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $503K | 0.03% |
65,374
-102,234
| -61% | -$787K |
|
|
AKTX
57
Akari Therapeutics
AKTX
$21.4M
| $452K | 0.02% |
22,608
| – | – |
|
|
58
Robinhood
HOOD
$89.6B
| – | – |
-47,664,177
| Closed | -$644M |
|
|
GNCA
59
DELISTED
Genocea Biosciences, Inc.
GNCA
| – | – |
-10,376,936
| Closed | -$13M |
|